3.26.1 html 166 277 1 false 48 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.anikatherapeutics.com/20260630/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://www.anikatherapeutics.com/20260630/role/statement-condensed-consolidated-balance-sheets-unaudited- Condensed Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) Sheet http://www.anikatherapeutics.com/20260630/role/statement-condensed-consolidated-balance-sheets-unaudited-parentheticals Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) Sheet http://www.anikatherapeutics.com/20260630/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-income-loss-unaudited- Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) Statements 4 false false R5.htm 004 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited) Sheet http://www.anikatherapeutics.com/20260630/role/statement-condensed-consolidated-statements-of-stockholders-equity-unaudited- Condensed Consolidated Statements of Stockholders' Equity (Unaudited) Statements 5 false false R6.htm 005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.anikatherapeutics.com/20260630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited- Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 006 - Disclosure - Note 1 - Nature of Business Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-1-nature-of-business Note 1 - Nature of Business Notes 7 false false R8.htm 007 - Disclosure - Note 2 - Basis of Presentation Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-2-basis-of-presentation Note 2 - Basis of Presentation Notes 8 false false R9.htm 008 - Disclosure - Note 3 - Discontinued Operations Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-3-discontinued-operations Note 3 - Discontinued Operations Notes 9 false false R10.htm 009 - Disclosure - Note 4 - Accounts Receivable Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-4-accounts-receivable Note 4 - Accounts Receivable Notes 10 false false R11.htm 010 - Disclosure - Note 5 - Fair Value Measurements Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-5-fair-value-measurements Note 5 - Fair Value Measurements Notes 11 false false R12.htm 011 - Disclosure - Note 6 - Inventories Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-6-inventories Note 6 - Inventories Notes 12 false false R13.htm 012 - Disclosure - Note 7 - Property and Equipment Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-7-property-and-equipment Note 7 - Property and Equipment Notes 13 false false R14.htm 013 - Disclosure - Note 8 - Goodwill and Intangible Assets Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-8-goodwill-and-intangible-assets Note 8 - Goodwill and Intangible Assets Notes 14 false false R15.htm 014 - Disclosure - Note 9 - Accrued Expenses and Other Current Liabilities Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-9-accrued-expenses-and-other-current-liabilities Note 9 - Accrued Expenses and Other Current Liabilities Notes 15 false false R16.htm 015 - Disclosure - Note 10 - Commitments and Contingencies Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-10-commitments-and-contingencies Note 10 - Commitments and Contingencies Notes 16 false false R17.htm 016 - Disclosure - Note 11 - Revenue and Geographic Information Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-11-revenue-and-geographic-information Note 11 - Revenue and Geographic Information Notes 17 false false R18.htm 017 - Disclosure - Note 12 - Equity Incentive Plans Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-12-equity-incentive-plans Note 12 - Equity Incentive Plans Notes 18 false false R19.htm 018 - Disclosure - Note 13 - Restructuring Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-13-restructuring Note 13 - Restructuring Notes 19 false false R20.htm 019 - Disclosure - Note 14 - Income Taxes Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-14-income-taxes Note 14 - Income Taxes Notes 20 false false R21.htm 020 - Disclosure - Note 15 - Earnings Per Share ("EPS") Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-15-earnings-per-share-eps Note 15 - Earnings Per Share ("EPS") Notes 21 false false R22.htm 021 - Disclosure - Note 16 - Share Repurchase Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-16-share-repurchase Note 16 - Share Repurchase Notes 22 false false R23.htm 022 - Disclosure - Note 17 - Segment Information Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-17-segment-information Note 17 - Segment Information Notes 23 false false R24.htm 023 - Disclosure - Note 18 - Subsequent Event Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-18-subsequent-event Note 18 - Subsequent Event Notes 24 false false R25.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 25 false false R26.htm 995445 - Disclosure - Note 3 - Discontinued Operations (Tables) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-3-discontinued-operations-tables Note 3 - Discontinued Operations (Tables) Tables http://www.anikatherapeutics.com/20260630/role/statement-note-3-discontinued-operations 26 false false R27.htm 995446 - Disclosure - Note 4 - Accounts Receivable (Tables) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-4-accounts-receivable-tables Note 4 - Accounts Receivable (Tables) Tables http://www.anikatherapeutics.com/20260630/role/statement-note-4-accounts-receivable 27 false false R28.htm 995447 - Disclosure - Note 5 - Fair Value Measurements (Tables) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-5-fair-value-measurements-tables Note 5 - Fair Value Measurements (Tables) Tables http://www.anikatherapeutics.com/20260630/role/statement-note-5-fair-value-measurements 28 false false R29.htm 995448 - Disclosure - Note 6 - Inventories (Tables) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-6-inventories-tables Note 6 - Inventories (Tables) Tables http://www.anikatherapeutics.com/20260630/role/statement-note-6-inventories 29 false false R30.htm 995449 - Disclosure - Note 7 - Property and Equipment (Tables) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-7-property-and-equipment-tables Note 7 - Property and Equipment (Tables) Tables http://www.anikatherapeutics.com/20260630/role/statement-note-7-property-and-equipment 30 false false R31.htm 995450 - Disclosure - Note 8 - Goodwill and Intangible Assets (Tables) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-8-goodwill-and-intangible-assets-tables Note 8 - Goodwill and Intangible Assets (Tables) Tables http://www.anikatherapeutics.com/20260630/role/statement-note-8-goodwill-and-intangible-assets 31 false false R32.htm 995451 - Disclosure - Note 9 - Accrued Expenses and Other Current Liabilities (Tables) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-9-accrued-expenses-and-other-current-liabilities-tables Note 9 - Accrued Expenses and Other Current Liabilities (Tables) Tables http://www.anikatherapeutics.com/20260630/role/statement-note-9-accrued-expenses-and-other-current-liabilities 32 false false R33.htm 995452 - Disclosure - Note 11 - Revenue and Geographic Information (Tables) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-11-revenue-and-geographic-information-tables Note 11 - Revenue and Geographic Information (Tables) Tables http://www.anikatherapeutics.com/20260630/role/statement-note-11-revenue-and-geographic-information 33 false false R34.htm 995453 - Disclosure - Note 12 - Equity Incentive Plans (Tables) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-12-equity-incentive-plans-tables Note 12 - Equity Incentive Plans (Tables) Tables http://www.anikatherapeutics.com/20260630/role/statement-note-12-equity-incentive-plans 34 false false R35.htm 995454 - Disclosure - Note 13 - Restructuring (Tables) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-13-restructuring-tables Note 13 - Restructuring (Tables) Tables http://www.anikatherapeutics.com/20260630/role/statement-note-13-restructuring 35 false false R36.htm 995455 - Disclosure - Note 15 - Earnings Per Share ("EPS") (Tables) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-15-earnings-per-share-eps-tables Note 15 - Earnings Per Share ("EPS") (Tables) Tables http://www.anikatherapeutics.com/20260630/role/statement-note-15-earnings-per-share-eps 36 false false R37.htm 995456 - Disclosure - Note 17 - Segment Information (Tables) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-17-segment-information-tables Note 17 - Segment Information (Tables) Tables http://www.anikatherapeutics.com/20260630/role/statement-note-17-segment-information 37 false false R38.htm 995457 - Disclosure - Note 3 - Discontinued Operations (Details Textual) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-3-discontinued-operations-details-textual Note 3 - Discontinued Operations (Details Textual) Details http://www.anikatherapeutics.com/20260630/role/statement-note-3-discontinued-operations-tables 38 false false R39.htm 995458 - Disclosure - Note 3 - Discontinued Operations - Schedule of Discontinued Operations (Details) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-3-discontinued-operations-schedule-of-discontinued-operations-details Note 3 - Discontinued Operations - Schedule of Discontinued Operations (Details) Details 39 false false R40.htm 995459 - Disclosure - Note 4 - Accounts Receivable (Details Textual) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-4-accounts-receivable-details-textual Note 4 - Accounts Receivable (Details Textual) Details http://www.anikatherapeutics.com/20260630/role/statement-note-4-accounts-receivable-tables 40 false false R41.htm 995460 - Disclosure - Note 4 - Accounts Receivable - Allowance for Doubtful Accounts (Details) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-4-accounts-receivable-allowance-for-doubtful-accounts-details Note 4 - Accounts Receivable - Allowance for Doubtful Accounts (Details) Details 41 false false R42.htm 995461 - Disclosure - Note 5 - Fair Value Measurements - Fair Value of Financial Instruments (Details) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-5-fair-value-measurements-fair-value-of-financial-instruments-details Note 5 - Fair Value Measurements - Fair Value of Financial Instruments (Details) Details 42 false false R43.htm 995462 - Disclosure - Note 6 - Inventories (Details Textual) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-6-inventories-details-textual Note 6 - Inventories (Details Textual) Details http://www.anikatherapeutics.com/20260630/role/statement-note-6-inventories-tables 43 false false R44.htm 995463 - Disclosure - Note 6 - Inventories - Summary of Inventories (Details) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-6-inventories-summary-of-inventories-details Note 6 - Inventories - Summary of Inventories (Details) Details 44 false false R45.htm 995464 - Disclosure - Note 7 - Property and Equipment (Details Textual) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-7-property-and-equipment-details-textual Note 7 - Property and Equipment (Details Textual) Details http://www.anikatherapeutics.com/20260630/role/statement-note-7-property-and-equipment-tables 45 false false R46.htm 995465 - Disclosure - Note 7 - Property and Equipment - Property and Equipment at Cost (Details) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-7-property-and-equipment-property-and-equipment-at-cost-details Note 7 - Property and Equipment - Property and Equipment at Cost (Details) Details 46 false false R47.htm 995466 - Disclosure - Note 8 - Goodwill and Intangible Assets (Details Textual) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-8-goodwill-and-intangible-assets-details-textual Note 8 - Goodwill and Intangible Assets (Details Textual) Details http://www.anikatherapeutics.com/20260630/role/statement-note-8-goodwill-and-intangible-assets-tables 47 false false R48.htm 995467 - Disclosure - Note 8 - Goodwill and Intangible Assets - Changes in the Carrying Value of Goodwill (Details) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-8-goodwill-and-intangible-assets-changes-in-the-carrying-value-of-goodwill-details Note 8 - Goodwill and Intangible Assets - Changes in the Carrying Value of Goodwill (Details) Details 48 false false R49.htm 995468 - Disclosure - Note 9 - Accrued Expenses and Other Current Liabilities - Summary of Accrued Expenses (Details) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-9-accrued-expenses-and-other-current-liabilities-summary-of-accrued-expenses-details Note 9 - Accrued Expenses and Other Current Liabilities - Summary of Accrued Expenses (Details) Details 49 false false R50.htm 995469 - Disclosure - Note 10 - Commitments and Contingencies (Details Textual) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-10-commitments-and-contingencies-details-textual Note 10 - Commitments and Contingencies (Details Textual) Details http://www.anikatherapeutics.com/20260630/role/statement-note-10-commitments-and-contingencies 50 false false R51.htm 995470 - Disclosure - Note 11 - Revenue and Geographic Information (Details Textual) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-11-revenue-and-geographic-information-details-textual Note 11 - Revenue and Geographic Information (Details Textual) Details http://www.anikatherapeutics.com/20260630/role/statement-note-11-revenue-and-geographic-information-tables 51 false false R52.htm 995471 - Disclosure - Note 11 - Revenue and Geographic Information - Revenues (Details) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-11-revenue-and-geographic-information-revenues-details Note 11 - Revenue and Geographic Information - Revenues (Details) Details http://www.anikatherapeutics.com/20260630/role/statement-note-11-revenue-and-geographic-information-tables 52 false false R53.htm 995472 - Disclosure - Note 11 - Revenue and Geographic Information - Total Revenue by Geographic Location (Details) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-11-revenue-and-geographic-information-total-revenue-by-geographic-location-details Note 11 - Revenue and Geographic Information - Total Revenue by Geographic Location (Details) Details 53 false false R54.htm 995473 - Disclosure - Note 12 - Equity Incentive Plans (Details Textual) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-12-equity-incentive-plans-details-textual Note 12 - Equity Incentive Plans (Details Textual) Details http://www.anikatherapeutics.com/20260630/role/statement-note-12-equity-incentive-plans-tables 54 false false R55.htm 995474 - Disclosure - Note 12 - Equity Incentive Plans - Share-Based Payment Arrangement, Expensed and Capitalized, Amount (Details) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-12-equity-incentive-plans-sharebased-payment-arrangement-expensed-and-capitalized-amount-details Note 12 - Equity Incentive Plans - Share-Based Payment Arrangement, Expensed and Capitalized, Amount (Details) Details 55 false false R56.htm 995475 - Disclosure - Note 12 - Equity Incentive Plans - Share-Based Payment Arrangement, Expensed and Capitalized, Amount 2 (Details) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-12-equity-incentive-plans-sharebased-payment-arrangement-expensed-and-capitalized-amount-2-details Note 12 - Equity Incentive Plans - Share-Based Payment Arrangement, Expensed and Capitalized, Amount 2 (Details) Details 56 false false R57.htm 995476 - Disclosure - Note 12 - Equity Incentive Plans - Share-Based Payment Arrangement, Option, Activity (Details) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-12-equity-incentive-plans-sharebased-payment-arrangement-option-activity-details Note 12 - Equity Incentive Plans - Share-Based Payment Arrangement, Option, Activity (Details) Details 57 false false R58.htm 995477 - Disclosure - Note 12 - Equity Incentive Plans - Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions (Details) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-12-equity-incentive-plans-schedule-of-sharebased-payment-award-stock-options-valuation-assumptions-details Note 12 - Equity Incentive Plans - Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions (Details) Details 58 false false R59.htm 995478 - Disclosure - Note 12 - Equity Incentive Plans - Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity (Details) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-12-equity-incentive-plans-sharebased-payment-arrangement-restricted-stock-and-restricted-stock-unit-activity-details Note 12 - Equity Incentive Plans - Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity (Details) Details 59 false false R60.htm 995479 - Disclosure - Note 12 - Equity Incentive Plans - Share-Based Payment Arrangement, Performance Shares, Activity (Details) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-12-equity-incentive-plans-sharebased-payment-arrangement-performance-shares-activity-details Note 12 - Equity Incentive Plans - Share-Based Payment Arrangement, Performance Shares, Activity (Details) Details 60 false false R61.htm 995480 - Disclosure - Note 13 - Restructuring (Details Textual) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-13-restructuring-details-textual Note 13 - Restructuring (Details Textual) Details http://www.anikatherapeutics.com/20260630/role/statement-note-13-restructuring-tables 61 false false R62.htm 995481 - Disclosure - Note 13 - Restructuring - Restructuring and Related Costs (Details) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-13-restructuring-restructuring-and-related-costs-details Note 13 - Restructuring - Restructuring and Related Costs (Details) Details 62 false false R63.htm 995482 - Disclosure - Note 14 - Income Taxes (Details Textual) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-14-income-taxes-details-textual Note 14 - Income Taxes (Details Textual) Details http://www.anikatherapeutics.com/20260630/role/statement-note-14-income-taxes 63 false false R64.htm 995483 - Disclosure - Note 15 - Earnings Per Share ("EPS") (Details Textual) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-15-earnings-per-share-eps-details-textual Note 15 - Earnings Per Share ("EPS") (Details Textual) Details http://www.anikatherapeutics.com/20260630/role/statement-note-15-earnings-per-share-eps-tables 64 false false R65.htm 995484 - Disclosure - Note 15 - Earnings Per Share ("EPS") - Basic and Diluted Earnings Per Share (Details) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-15-earnings-per-share-eps-basic-and-diluted-earnings-per-share-details Note 15 - Earnings Per Share ("EPS") - Basic and Diluted Earnings Per Share (Details) Details http://www.anikatherapeutics.com/20260630/role/statement-note-15-earnings-per-share-eps-tables 65 false false R66.htm 995485 - Disclosure - Note 16 - Share Repurchase (Details Textual) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-16-share-repurchase-details-textual Note 16 - Share Repurchase (Details Textual) Details http://www.anikatherapeutics.com/20260630/role/statement-note-16-share-repurchase 66 false false R67.htm 995486 - Disclosure - Note 17 - Segment Information (Details Textual) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-17-segment-information-details-textual Note 17 - Segment Information (Details Textual) Details http://www.anikatherapeutics.com/20260630/role/statement-note-17-segment-information-tables 67 false false R68.htm 995487 - Disclosure - Note 17 - Segment Information - Summary Of Segment Information (Details) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-17-segment-information-summary-of-segment-information-details Note 17 - Segment Information - Summary Of Segment Information (Details) Details 68 false false R69.htm 995488 - Disclosure - Note 18 - Subsequent Event (Details Textual) Sheet http://www.anikatherapeutics.com/20260630/role/statement-note-18-subsequent-event-details-textual Note 18 - Subsequent Event (Details Textual) Details http://www.anikatherapeutics.com/20260630/role/statement-note-18-subsequent-event 69 false false All Reports Book All Reports anik-20260630.xsd anik-20260630_cal.xml anik-20260630_def.xml anik-20260630_lab.xml anik-20260630_pre.xml anik20260630_10q.htm http://fasb.org/srt/2026 http://fasb.org/us-gaap/2026 http://xbrl.sec.gov/dei/2026 http://xbrl.sec.gov/ecd/2026 true true